208 related articles for article (PubMed ID: 17804556)
1. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis.
Jönsson M; Norrgård O; Hansson M; Forsgren S
Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556
[TBL] [Abstract][Full Text] [Related]
2. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
3. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
[TBL] [Abstract][Full Text] [Related]
4. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
Jönsson M; Norrgård O; Forsgren S
Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
[TBL] [Abstract][Full Text] [Related]
5. Substance P and the neurokinin-1 receptor in relation to eosinophilia in ulcerative colitis.
Jönsson M; Norrgård O; Forsgren S
Peptides; 2005 May; 26(5):799-814. PubMed ID: 15808910
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
[TBL] [Abstract][Full Text] [Related]
7. [Expression with TGFbeta1 in the patients with ulcerative colitis].
Wang YF; Wei B; Ouyang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):204-6. PubMed ID: 15807267
[TBL] [Abstract][Full Text] [Related]
8. The lipocortin of colon mucosa in ulcerative colitis.
Sakanoue Y; Kusunoki M; Hatada T; Sakiyama T; Fujita S; Yamamura T; Utsunomiya J
Horm Metab Res; 1990 Aug; 22(8):453-4. PubMed ID: 2146205
[No Abstract] [Full Text] [Related]
9. Colonic vasoactive intestinal polypeptide in ulcerative colitis.
Surrenti C; Renzi D; Garcea MR; Surrenti E; Salvadori G
J Physiol Paris; 1993; 87(5):307-11. PubMed ID: 8298608
[TBL] [Abstract][Full Text] [Related]
10. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide and its relationship to tumor stage in colorectal carcinoma: an immunohistochemical study.
Hirayasu Y; Oya M; Okuyama T; Kiumi F; Ueda Y
J Gastroenterol; 2002; 37(5):336-44. PubMed ID: 12051532
[TBL] [Abstract][Full Text] [Related]
12. Lipoxin biosynthesis in inflammatory bowel disease.
Mangino MJ; Brounts L; Harms B; Heise C
Prostaglandins Other Lipid Mediat; 2006 Mar; 79(1-2):84-92. PubMed ID: 16516812
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
14. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide (VIP) receptors in the canine gastrointestinal tract.
Zimmerman RP; Gates TS; Mantyh CR; Vigna SR; Boehmer CG; Mantyh PW
Peptides; 1988; 9(6):1241-53. PubMed ID: 2854625
[TBL] [Abstract][Full Text] [Related]
16. [Functional state of the gastric antrum endocrinal cells containing serotonin in nonspecific ulcerative colitis].
Isaev GB; Alieva AM
Klin Khir; 2014 Jun; (6):14-6. PubMed ID: 25252544
[TBL] [Abstract][Full Text] [Related]
17. Atypical mitoses in colectomy specimens from patients with long standing ulcerative colitis.
Rubio CA; Befrits R
Anticancer Res; 1997; 17(4A):2721-6. PubMed ID: 9252704
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
Danelius M; Ost A; Lapidus AB
Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
[TBL] [Abstract][Full Text] [Related]
19. Binding sites for VIP in the reorganizing mucosa of the irradiated bowel.
Höckerfelt U; Hansson M; Gulbenkian S; Franzén L; Henriksson R; Forsgren S
Ann N Y Acad Sci; 1998 Dec; 865():344-52. PubMed ID: 9928028
[TBL] [Abstract][Full Text] [Related]
20. Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.
Schulte-Bockholt A; Fink JG; Meier DA; Otterson MF; Telford GL; Hopp K; Koch TR
Mol Cell Biochem; 1995 Jan; 142(1):1-7. PubMed ID: 7753037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
